Huang Ting-Ting, Sun Wen-Juan, Liu Hai-Ying, Ma Hong-Li, Cui Bao-Xia
Cheeloo College of Medicine, Shandong University, Jinan 250000, Shandong Province, China.
Department of Obstetrics, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250000, Shandong Province, China.
World J Diabetes. 2021 Nov 15;12(11):1894-1907. doi: 10.4239/wjd.v12.i11.1894.
Gestational diabetes mellitus (GDM) is associated with a heightened level of oxidative stress, which is characterized by the overproduction of reactive oxygen species (ROS) from mitochondria. Previous studies showed that mitochondrial dysfunction is regulated by dynamin-related protein 1 (Drp1) and p66Shc in GDM.
The aim was to investigate the expression of Drp1 and p66Shc and their possible mechanisms in the pathogenesis of GDM.
A total of 30 pregnant women, 15 with GDM and 15 without GDM, were enrolled. Peripheral blood mononuclear cells and placental tissue were collected. The human JEG3 trophoblast cell line was cultivated in 5.5 mmol/L or 30 mmol/L glucose and transfected with wild-type (wt)-p66Shc and p66Shc siRNA. P66Shc and Drp1 mRNA levels were detected by quantitative real-time polymerase chain reaction. The expression of p66Shc and Drp1 was assayed by immunohistochemistry and western blotting. ROS was assayed by dihydroethidium staining.
The p66Shc mRNA level was increased in the serum ( < 0.01) and placentas ( < 0.01) of women with GDM, and the expression of Drp1 mRNA and protein were also increased in placentas ( < 0.05). In JEG3 cells treated with 30 mmol/L glucose, the mRNA and protein expression of p66Shc and Drp1 were increased at 24 h (both < 0.05), 48 h (both < 0.01) and 72 h (both < 0.001). ROS expression was also increased. High levels of Drp1 and ROS expression were detected in JEG3 cells transfected with wt-p66Shc ( < 0.01), and low levels were detected in JEG3 cells transfected with p66Shc siRNA ( < 0.05).
The upregulated expression of Drp1 and p66shc may contribute to the occurrence and development of GDM. Regulation of the mitochondrial fusion-fission balance could be a novel strategy for GDM treatment.
妊娠期糖尿病(GDM)与氧化应激水平升高有关,其特征是线粒体产生过量的活性氧(ROS)。先前的研究表明,在GDM中,动力相关蛋白1(Drp1)和p66Shc调节线粒体功能障碍。
研究Drp1和p66Shc的表达及其在GDM发病机制中的可能作用机制。
共纳入30名孕妇,其中15例为GDM患者,15例为非GDM患者。采集外周血单个核细胞和胎盘组织。将人JEG3滋养层细胞系培养在5.5 mmol/L或30 mmol/L葡萄糖中,并用野生型(wt)-p66Shc和p66Shc siRNA转染。通过定量实时聚合酶链反应检测P66Shc和Drp1 mRNA水平。通过免疫组织化学和蛋白质印迹法检测p66Shc和Drp1的表达。通过二氢乙锭染色检测ROS。
GDM患者血清(<0.01)和胎盘(<0.01)中p66Shc mRNA水平升高,胎盘组织中Drp1 mRNA和蛋白表达也增加(<0.05)。在30 mmol/L葡萄糖处理的JEG3细胞中,p66Shc和Drp1的mRNA和蛋白表达在24小时(均<0.05)、48小时(均<0.01)和72小时(均<0.001)时增加。ROS表达也增加。在转染wt-p66Shc的JEG3细胞中检测到高水平的Drp1和ROS表达(<0.01),而在转染p66Shc siRNA的JEG3细胞中检测到低水平(<0.05)。
Drp1和p66shc的表达上调可能有助于GDM的发生和发展。调节线粒体融合-分裂平衡可能是GDM治疗的新策略。